Neurocrine Biosciences
NBIX
#1387
Rank
$16.19 B
Marketcap
$161.10
Share price
-0.99%
Change (1 day)
29.74%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Stock price history for Neurocrine Biosciences (NBIX)

Highest end of day price: $167.35 USD on 2026-06-04

Lowest end of day price: $2.00 USD on 2009-11-12

Stock price history of Neurocrine Biosciences from 1996 to 2026

Annual Stock Price Performance

Year Performance
2026 14.72%
2025 2.88%
2024 3.62%
2023 9.73%
2022 35.01%
2021-11.16%
2020-11.50%
2019 53.36%
2018-9.95%
2017 100.70%
2016-26.07%
2015 147.68%
2014 133.93%
2013 14.74%
2012-12.51%
2011 10.82%
2010 184.01%
2009-16.82%
2008-29.20%
2007-55.79%
2006-83.61%
2005 27.97%
2004-11.17%
2003 20.11%
2002-9.71%
2001 59.41%
2000 31.84%
1999 260.00%
1998-17.29%
1997-17.65%
1996-20.00%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$26.30 0.52%๐Ÿ‡บ๐Ÿ‡ธ USA
$225.36 0.26%๐Ÿ‡บ๐Ÿ‡ธ USA
$1,152-0.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$132.98-0.26%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.01350-33.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$82.22 0.70%๐Ÿ‡บ๐Ÿ‡ธ USA
$13.68 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$55.00-0.52%๐Ÿ‡ฌ๐Ÿ‡ง UK